FINWIRES · TerminalLIVE
FINWIRES

德國DAX指數變化不大;3月德國通膨率創兩年新高

-- 藍籌股DAX指數週五收盤下跌0.01%,與前一日持平,市場的焦點是即將舉行的美伊談判。 以色列表示願意與黎巴嫩進行對話後,人們對地區局勢降溫以及霍爾木茲海峽重新開放的希望增加。德黑蘭方面一直強調,以色列在黎巴嫩持續進行的軍事行動是與華盛頓達成更廣泛停火協議的主要障礙。美伊將於週六在巴基斯坦舉行備受矚目的談判。 在德國國內經濟新聞方面,德國聯邦統計局(Destatis)在最終數據中確認,德國2026年3月的年通膨率將從先前公佈的1.9%加速至2.7%,創下自2024年1月以來的最高水準。剔除食品和能源價格的核心通膨率維持在2.5%不變。 「能源產品價格的大幅上漲推高了通貨膨脹。特別是自伊朗戰爭爆發以來,消費者的車用燃油和取暖油價格都大幅上漲,」德國聯邦統計局長露絲布蘭德表示。 根據ifo經濟研究所最新的商業調查,中東衝突也對德國旅遊業造成了衝擊。 ifo旅遊機構和旅行社的商業景氣指數從-14.8點暴跌至-41.7點,反映出人們對當前情勢和未來預期更加悲觀。 此外,ifo指出,由於燃油成本上漲,越來越多的旅遊機構和旅行社預計未來幾個月旅遊服務成本將會上升。 「隨著時間的推移,通貨膨脹率的上升可能會給許多度假者的旅行預算帶來壓力,」行業專家帕特里克·霍普納表示。 在企業方面,諾德克斯公司(NDX1.F)獲得了西班牙一個未公開的風電場專案的訂單,將為其提供13台N175/6.X型風力渦輪機。該交易初始裝置容量為 80 兆瓦,並可選擇將總裝置容量擴大至 120 兆瓦。德國風力渦輪機製造商西門子在 Xetra 交易所的股價在當日收盤時下跌了 0.39%。 同時,受台灣晶片製造商台積電第一季營收超出預期(主要得益於人工智慧相關需求的成長)的提振,西門子 (SIE.F) 和英飛凌科技 (IFX.F) 成為 DAX 指數表現最佳的股票之一,分別上漲了 1.32% 和 1.03%。

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB